Direktorat Registrasi ObatValid

KADCYLA

BPOM Number: DKI2157509244B1
Approved: 21 November 2024
Expiry: 20 December 2026
Form: SERBUK INJEKSI; 160 MG

About This Registration

KADCYLA is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2157509244B1. Its current registration status is Valid, with the licence valid until 20 December 2026. The product is registered to MENARINI INDRIA LABORATORIES - INDONESIA. BPOM first approved this registration in December 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 1 VIAL @ 160 MG
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

MENARINI INDRIA LABORATORIES - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

MENARINI INDRIA LABORATORIES - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

TRASTUZUMAB EMTANSINE

Market Intelligence

Owner Portfolio: MENARINI INDRIA LABORATORIES - INDONESIA holds 98 BPOM registrations
Manufacturer Scale: MENARINI INDRIA LABORATORIES - INDONESIA produces 98 registered products
Registration Age: Registered for 4 years, 9 months
Expiry Status: Expires in 86 days